{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,11]],"date-time":"2026-08-11T11:35:42Z","timestamp":1786448142266,"version":"build-2736575974"},"reference-count":50,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,6,3]],"date-time":"2026-06-03T00:00:00Z","timestamp":1780444800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,8,11]],"date-time":"2026-08-11T00:00:00Z","timestamp":1786406400000},"content-version":"vor","delay-in-days":69,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"Sun Yat-sen Pilot Scientific Research Fund","award":["SYSQH-II-2026-08"],"award-info":[{"award-number":["SYSQH-II-2026-08"]}]},{"name":"Guangdong Clinical Research Center for Metabolic Diseases","award":["2020B1111170009"],"award-info":[{"award-number":["2020B1111170009"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cardiovasc Diabetol"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Cardiometabolic multimorbidity (CMM) burdens aging populations. Obesity drives CMM via insulin resistance and inflammation, but their nonlinear and combined effects remain unclear. We elucidated how these factors contribute to CMM incidence.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>From CHARLS 2011 to 2018, 6,510 participants were enrolled. CMM was defined as \u2265\u20092 of diabetes, heart disease, and stroke. Cox regression, Kaplan-Meier, and Fine-Gray models were used. Restricted cubic splines (RCS) evaluated nonlinear relationships. Multiplicative and additive interactions were assessed, and mediation analysis with 1,000 bootstraps estimated indirect effects. K-means clustering based on eight standardized variables, including age, body mass index (BMI), waist circumference (WC), triglyceride-glucose (TyG), high-sensitivity C-reactive protein (hs-CRP), systolic blood pressure (SBP), high-density lipoprotein cholesterol (HDL-C), and fasting plasma glucose (FPG), identified metabolic phenotypes carried high CMM risk.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>Over 7 years, 212 (3.26%) developed CMM. RCS revealed a J-shaped association between WC and CMM. Optimal cut-offs were 60 years for age, 25.6\u00a0kg\/m\u00b2 for BMI, 90.6\u00a0cm for WC, 8.7 for the TyG index, 154.3\u00a0mg\/dL for LDL-C, and 0.86\u00a0mg\/L for hs-CRP. All six parameters independently predicted CMM. No significant additive interactions were found, but dual elevation markedly increased risk. The TyG index mediated 14.6% of the BMI effect and 10.0% of the WC effect on CMM. Clustering identified insulin-resistant and obese-insulin-resistant phenotypes.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>Optimal cut-offs offer practical screening tools. Dual elevation markedly increases CMM risk and insulin resistance mediates adiposity effects. Clustering identified insulin-resistant and obese-insulin-resistant phenotypes, supporting phenotype-based prevention.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s12933-026-03234-9","type":"journal-article","created":{"date-parts":[[2026,6,3]],"date-time":"2026-06-03T15:45:20Z","timestamp":1780501520000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Effects of adiposity, insulin resistance, and inflammation on cardiometabolic multimorbidity: insights from interaction analyses and metabolic phenotyping in the China health and retirement longitudinal study 2011\u20132018"],"prefix":"10.1186","volume":"25","author":[{"given":"Lili","family":"You","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wenbo","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Meiguang","family":"Zheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaosi","family":"Hong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Meng","family":"Ren","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wenpeng","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,6,3]]},"reference":[{"issue":"9836","key":"3234_CR1","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1016\/S0140-6736(12)60240-2","volume":"380","author":"K Barnett","year":"2012","unstructured":"Barnett K, Mercer SW, Norbury M, Watt G, Wyke S, Guthrie B. Epidemiology of multimorbidity and implications for health care, research, and medical education: a cross-sectional study. Lancet. 2012;380(9836):37\u201343.","journal-title":"Lancet"},{"issue":"34","key":"3234_CR2","doi-asserted-by":"publisher","first-page":"3374","DOI":"10.1093\/eurheartj\/ehab413","volume":"42","author":"Y Han","year":"2021","unstructured":"Han Y, Hu Y, Yu C, Guo Y, Pei P, Yang L, Chen Y, Du H, Sun D, Pang Y, Chen N, Clarke R, Chen J, Chen Z, Li L, Lv J. Lifestyle, cardiometabolic disease, and multimorbidity in a prospective Chinese study. Eur Heart J. 2021;42(34):3374\u201384.","journal-title":"Eur Heart J"},{"issue":"3","key":"3234_CR3","doi-asserted-by":"publisher","first-page":"821","DOI":"10.1002\/alz.12708","volume":"19","author":"A Dove","year":"2023","unstructured":"Dove A, Marseglia A, Shang Y, Grande G, Vetrano DL, Laukka EJ, Fratiglioni L, Xu W. Cardiometabolic multimorbidity accelerates cognitive decline and dementia progression. Alzheimers Dement. 2023;19(3):821\u201330.","journal-title":"Alzheimers Dement"},{"issue":"7","key":"3234_CR4","doi-asserted-by":"publisher","first-page":"573","DOI":"10.1093\/eurheartj\/ehac744","volume":"44","author":"A Dove","year":"2023","unstructured":"Dove A, Guo J, Marseglia A, Fastbom J, Vetrano DL, Fratiglioni L, Pedersen NL, Xu W. Cardiometabolic multimorbidity and incident dementia: the Swedish twin registry. Eur Heart J. 2023;44(7):573\u201382.","journal-title":"Eur Heart J"},{"issue":"1","key":"3234_CR5","doi-asserted-by":"publisher","first-page":"9","DOI":"10.5334\/gh.1188","volume":"18","author":"P Otieno","year":"2023","unstructured":"Otieno P, Asiki G, Aheto JMK, Wilunda C, Sanya RE, Wami W, Mwanga D, Agyemang C. Cardiometabolic multimorbidity associated with moderate and severe disabilities: results from the study on global ageing and adult health (SAGE) Wave 2 in Ghana and South Africa. Glob Heart. 2023;18(1):9.","journal-title":"Glob Heart"},{"issue":"1","key":"3234_CR6","doi-asserted-by":"publisher","first-page":"258","DOI":"10.1186\/s12916-021-02126-x","volume":"19","author":"D Canoy","year":"2021","unstructured":"Canoy D, Tran J, Zottoli M, Ramakrishnan R, Hassaine A, Rao S, Li Y, Salimi-Khorshidi G, Norton R, Rahimi K. Association between cardiometabolic disease multimorbidity and all-cause mortality in 2 million women and men registered in UK general practices. BMC Med. 2021;19(1):258.","journal-title":"BMC Med"},{"issue":"34","key":"3234_CR7","doi-asserted-by":"publisher","first-page":"3388","DOI":"10.1093\/eurheartj\/ehab454","volume":"42","author":"MS Kim","year":"2021","unstructured":"Kim MS, Kim WJ, Khera AV, Kim JY, Yon DK, Lee SW, Shin JI, Won HH. Association between adiposity and cardiovascular outcomes: an umbrella review and meta-analysis of observational and Mendelian randomization studies. Eur Heart J. 2021;42(34):3388\u2013403.","journal-title":"Eur Heart J"},{"issue":"3","key":"3234_CR8","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1038\/s41574-019-0310-7","volume":"16","author":"R Ross","year":"2020","unstructured":"Ross R, Neeland IJ, Yamashita S, Shai I, Seidell J, Magni P, Santos RD, Arsenault B, Cuevas A, Hu FB, Griffin BA, Zambon A, Barter P, Fruchart JC, Eckel RH, Matsuzawa Y, Despr\u00e9s JP. Waist circumference as a vital sign in clinical practice: a consensus statement from the IAS and ICCR Working Group on Visceral Obesity. Nat Rev Endocrinol. 2020;16(3):177\u201389.","journal-title":"Nat Rev Endocrinol"},{"issue":"9","key":"3234_CR9","doi-asserted-by":"publisher","first-page":"2395","DOI":"10.1038\/s41591-024-03095-3","volume":"30","author":"L Busetto","year":"2024","unstructured":"Busetto L, Dicker D, Fr\u00fchbeck G, Halford JCG, Sbraccia P, Yumuk V, Goossens GH. A new framework for the diagnosis, staging and management of obesity in adults. Nat Med. 2024;30(9):2395\u201399.","journal-title":"Nat Med"},{"key":"3234_CR10","doi-asserted-by":"crossref","unstructured":"Kojta I, Chaci\u0144ska M, B\u0142achnio-Zabielska A, Obesity. Bioactive Lipids, and Adipose Tissue Inflammation in Insulin Resistance. Nutrients2020;12(5).","DOI":"10.3390\/nu12051305"},{"issue":"11","key":"3234_CR11","doi-asserted-by":"publisher","first-page":"1549","DOI":"10.1161\/CIRCRESAHA.119.315896","volume":"126","author":"H Wu","year":"2020","unstructured":"Wu H, Ballantyne CM. Metabolic inflammation and insulin resistance in obesity. Circ Res. 2020;126(11):1549\u201364.","journal-title":"Circ Res"},{"issue":"1","key":"3234_CR12","doi-asserted-by":"publisher","first-page":"257","DOI":"10.1186\/s12933-025-02819-0","volume":"24","author":"Z Tian","year":"2025","unstructured":"Tian Z, Yang L, Li Y, Huang Y, Yang J, Xue F. Associations of different insulin resistance-related indices with the incidence and progression trajectory of cardiometabolic multimorbidity: a prospective cohort study from UK biobank. Cardiovasc Diabetol. 2025;24(1):257.","journal-title":"Cardiovasc Diabetol"},{"issue":"1","key":"3234_CR13","doi-asserted-by":"publisher","first-page":"22635","DOI":"10.1038\/s41598-024-72988-7","volume":"14","author":"W Cheng","year":"2024","unstructured":"Cheng W, Du Z, Lu B. Chronic low-grade inflammation associated with higher risk and earlier onset of cardiometabolic multimorbidity in middle-aged and older adults: a population-based cohort study. Sci Rep. 2024;14(1):22635.","journal-title":"Sci Rep"},{"key":"3234_CR14","doi-asserted-by":"publisher","first-page":"1511319","DOI":"10.3389\/fendo.2025.1511319","volume":"16","author":"B Wan","year":"2025","unstructured":"Wan B, Wang S, Hu S, Han W, Qiu S, Zhu L, Ruan L, Wei Y, Xu J. The comprehensive effects of high-sensitivity C-reactive protein and triglyceride glucose index on cardiometabolic multimorbidity. Front Endocrinol (Lausanne). 2025;16:1511319.","journal-title":"Front Endocrinol (Lausanne)"},{"issue":"11","key":"3234_CR15","doi-asserted-by":"publisher","first-page":"1871","DOI":"10.1093\/aje\/kwz170","volume":"188","author":"X Chen","year":"2019","unstructured":"Chen X, Crimmins E, Hu PP, Kim JK, Meng Q, Strauss J, Wang Y, Zeng J, Zhang Y, Zhao Y. Venous blood-based biomarkers in the China Health and retirement longitudinal study: rationale, design, and results from the 2015 wave. Am J Epidemiol. 2019;188(11):1871\u201377.","journal-title":"Am J Epidemiol"},{"issue":"1","key":"3234_CR16","doi-asserted-by":"publisher","first-page":"247","DOI":"10.1186\/s12933-024-02336-6","volume":"23","author":"Q Ren","year":"2024","unstructured":"Ren Q, Huang Y, Liu Q, Chu T, Li G, Wu Z. Association between triglyceride glucose-waist height ratio index and cardiovascular disease in middle-aged and older Chinese individuals: a nationwide cohort study. Cardiovasc Diabetol. 2024;23(1):247.","journal-title":"Cardiovasc Diabetol"},{"issue":"3","key":"3234_CR17","first-page":"245","volume":"15","author":"BF Zhou","year":"2002","unstructured":"Zhou BF. Effect of body mass index on all-cause mortality and incidence of cardiovascular diseases\u2013report for meta-analysis of prospective studies open optimal cut-off points of body mass index in Chinese adults. Biomed Environ Sci. 2002;15(3):245\u201352.","journal-title":"Biomed Environ Sci"},{"issue":"3","key":"3234_CR18","doi-asserted-by":"publisher","first-page":"287","DOI":"10.1111\/j.1467-789X.2011.00944.x","volume":"13","author":"B Xi","year":"2012","unstructured":"Xi B, Liang Y, He T, Reilly KH, Hu Y, Wang Q, Yan Y, Mi J. Secular trends in the prevalence of general and abdominal obesity among Chinese adults, 1993\u20132009. Obes Rev. 2012;13(3):287\u201396.","journal-title":"Obes Rev"},{"issue":"4","key":"3234_CR19","doi-asserted-by":"publisher","first-page":"253","DOI":"10.1038\/hr.2014.20","volume":"37","author":"K Shimamoto","year":"2014","unstructured":"Shimamoto K, Ando K, Fujita T, Hasebe N, Higaki J, Horiuchi M, Imai Y, Imaizumi T, Ishimitsu T, Ito M, Ito S, Itoh H, Iwao H, Kai H, Kario K, Kashihara N, Kawano Y, Kim-Mitsuyama S, Kimura G, Kohara K, Komuro I, Kumagai H, Matsuura H, Miura K, Morishita R, Naruse M, Node K, Ohya Y, Rakugi H, Saito I, Saitoh S, Shimada K, Shimosawa T, Suzuki H, Tamura K, Tanahashi N, Tsuchihashi T, Uchiyama M, Ueda S, Umemura S. The Japanese society of hypertension guidelines for the management of hypertension (JSH 2014). Hypertens Res. 2014;37(4):253\u2013390.","journal-title":"Hypertens Res"},{"issue":"1","key":"3234_CR20","doi-asserted-by":"publisher","first-page":"58","DOI":"10.1016\/j.diabres.2005.11.009","volume":"73","author":"GT Ko","year":"2006","unstructured":"Ko GT, Cockram CS, Chow CC, Yeung VT, Chan WB, So WY, Chan NN, Chan JC. Metabolic syndrome by the international diabetes federation definition in Hong Kong Chinese. Diabetes Res Clin Pract. 2006;73(1):58\u201364.","journal-title":"Diabetes Res Clin Pract"},{"issue":"Suppl 1","key":"3234_CR21","first-page":"S20","volume":"47","author":"2","year":"2024","unstructured":"2. Diagnosis and classification of diabetes: standards of care in diabetes-2024. Diabetes Care. 2024;47(Suppl 1):S20\u201342.","journal-title":"Diabetes Care"},{"issue":"1","key":"3234_CR22","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1093\/ije\/dys203","volume":"43","author":"Y Zhao","year":"2014","unstructured":"Zhao Y, Hu Y, Smith JP, Strauss J, Yang G. Cohort profile: the China Health and Retirement Longitudinal Study (CHARLS). Int J Epidemiol. 2014;43(1):61\u20138.","journal-title":"Int J Epidemiol"},{"key":"3234_CR23","doi-asserted-by":"crossref","unstructured":"Du J, Man Z, Bai X, Luo D, Guo Q, Wang Y, Yan Y, Su X, Zheng W. Association of C-reactive protein-triglycerides-glucose index-waist to height ratio and cardiometabolic multimorbidity in middle-aged and older adults: a nationwide cohort study. Cardiovasc Diabetol2026;25(1).","DOI":"10.1186\/s12933-026-03151-x"},{"issue":"1","key":"3234_CR24","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1186\/s12933-025-02667-y","volume":"24","author":"H Lai","year":"2025","unstructured":"Lai H, Tu Y, Liao C, Zhang S, He L, Li J. Joint assessment of abdominal obesity and non-traditional lipid parameters for primary prevention of cardiometabolic multimorbidity: insights from the China health and retirement longitudinal study 2011\u20132018. Cardiovasc Diabetol. 2025;24(1):109.","journal-title":"Cardiovasc Diabetol"},{"key":"3234_CR25","doi-asserted-by":"crossref","unstructured":"Zheng W, Man Z, Ren Y, Li Y, Zhu X, Wang L, Zhang X, Hu G, Cao Y. Association of the triglyceride glucose-Chinese visceral adiposity index with incident cardiometabolic multimorbidity in middle-aged and older adults: a nationwide prospective cohort study. Cardiovasc Diabetol2026;25(1).","DOI":"10.1186\/s12933-026-03091-6"},{"issue":"7","key":"3234_CR26","doi-asserted-by":"publisher","first-page":"e083443","DOI":"10.1136\/bmjopen-2023-083443","volume":"14","author":"H Lin","year":"2024","unstructured":"Lin H, Xiao N, Lin S, Liu M, Liu GG. Associations of hypertension, diabetes and heart disease risk with body mass index in older Chinese adults: a population-based cohort study. BMJ Open. 2024;14(7):e083443.","journal-title":"BMJ Open"},{"issue":"1","key":"3234_CR27","doi-asserted-by":"publisher","first-page":"333","DOI":"10.1186\/s12889-025-26060-2","volume":"26","author":"L Zhang","year":"2025","unstructured":"Zhang L, Liu Z, Si D, Yang H, Fan X, Yan L, Liu J, Li X, Hu J, Wu J. Comparative predictive values of anthropometric indices for cardiometabolic multimorbidity in middle-aged and older adults: a prospective study from the CHARLS study. BMC Public Health. 2025;26(1):333.","journal-title":"BMC Public Health"},{"issue":"1","key":"3234_CR28","doi-asserted-by":"publisher","first-page":"284","DOI":"10.1186\/s40001-026-03906-y","volume":"31","author":"S Wei","year":"2026","unstructured":"Wei S, Yu S, Qian C, Lan Y, Xufeng H. Unveiling the relationship between stress-hyperglycemia ratio and cardiometabolic multimorbidity risk using interpretable machine learning. Eur J Med Res. 2026;31(1):284.","journal-title":"Eur J Med Res"},{"issue":"12","key":"3234_CR29","doi-asserted-by":"publisher","first-page":"926","DOI":"10.1111\/1753-0407.12785","volume":"10","author":"H Ma","year":"2018","unstructured":"Ma H, Wu X, Guo X, Yang J, Ma X, Lv M, Li Y. Optimal body mass index cut-off points for prediction of incident diabetes in a Chinese population. J Diabetes. 2018;10(12):926\u201333.","journal-title":"J Diabetes"},{"issue":"1","key":"3234_CR30","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1007\/s00394-015-1069-9","volume":"56","author":"HS Kruger","year":"2017","unstructured":"Kruger HS, Schutte AE, Walsh CM, Kruger A, Rennie KL. Body mass index cut-points to identify cardiometabolic risk in black South Africans. Eur J Nutr. 2017;56(1):193\u2013202.","journal-title":"Eur J Nutr"},{"key":"3234_CR31","doi-asserted-by":"crossref","unstructured":"Hamzeh B, Bagheri A, Pasdar Y, Darbandi M, Rezaeian S, Najafi F, Moradinazar M. Predicting metabolic syndrome by anthropometric measures among adults 35\u201365 years in the west of Iran; a cross sectional study from an Iranian RaNCD cohort data. Diabetes Metab Syndr2020 Sep-Oct;14(5):1293\u201398.","DOI":"10.1016\/j.dsx.2020.07.017"},{"issue":"1","key":"3234_CR32","doi-asserted-by":"publisher","first-page":"102","DOI":"10.1177\/0733464812464428","volume":"34","author":"ES So","year":"2015","unstructured":"So ES, Yoo KS. Waist circumference cutoff points for central obesity in the Korean elderly population. J Appl Gerontol. 2015;34(1):102\u201317.","journal-title":"J Appl Gerontol"},{"key":"3234_CR33","doi-asserted-by":"crossref","unstructured":"Li C, Luo X, Chen Y, Lin J, Gu S. Predictive value of an integrated insulin resistance and lipometabolic score for cardiometabolic multimorbidity in older adults: a UK cohort study. Cardiovasc Diabetol2026;25(1).","DOI":"10.1186\/s12933-025-03064-1"},{"issue":"1","key":"3234_CR34","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1186\/s12944-025-02836-8","volume":"25","author":"F Zhang","year":"2025","unstructured":"Zhang F, Zhang B, Huang X, Wang Z, Wang J, Lan H, Xie G, Wang W, Zou Y, Wang C. Comparison of the TyG index, TyG-traditional obesity indices, and TyG-novel obesity indices: does increased complexity help in predicting cardiometabolic multimorbidity? Lipids Health Dis. 2025;25(1):33.","journal-title":"Lipids Health Dis"},{"key":"3234_CR35","doi-asserted-by":"crossref","unstructured":"Liao C, Liu H, Xu S, Ling Z, Zhuo Y, Huang G, Lin W, Zhang Z. Associations of TyG-derived indices with cardiometabolic multimorbidity risk in community-dwelling older adults: a longitudinal analysis based on the gold-health cohort. Nutrients2026;18(6).","DOI":"10.3390\/nu18060985"},{"issue":"9","key":"3234_CR36","doi-asserted-by":"publisher","first-page":"e0163465","DOI":"10.1371\/journal.pone.0163465","volume":"11","author":"DY Lee","year":"2016","unstructured":"Lee DY, Lee ES, Kim JH, Park SE, Park CY, Oh KW, Park SW, Rhee EJ, Lee WY. Predictive value of triglyceride glucose index for the risk of incident diabetes: a 4-year retrospective longitudinal study. PLoS ONE. 2016;11(9):e0163465.","journal-title":"PLoS ONE"},{"key":"3234_CR37","unstructured":"P\u0142\u00f3ciniczak A, Dzi\u0119gielewska-G\u0119siak S, Bro\u017cek A, Blacha A, Nowicki M, Formanowicz D. High sensitivity C-reactive protein as a cardiovascular risk marker in independent community-living elderly persons. J Biol Regul Homeost Agents2018 Sep-Oct;32(5):1199\u2013204."},{"issue":"5","key":"3234_CR38","doi-asserted-by":"publisher","first-page":"672","DOI":"10.1002\/jcla.21920","volume":"30","author":"M Ebrahimi","year":"2016","unstructured":"Ebrahimi M, Heidari-Bakavoli AR, Shoeibi S, Mirhafez SR, Moohebati M, Esmaily H, Ghazavi H, Saberi Karimian M, Parizadeh SM, Mohammadi M, Mohaddes Ardabili H, Ferns GA, Ghayour-Mobarhan M. Association of serum hs-CRP levels with the presence of obesity, diabetes mellitus, and other cardiovascular risk factors. J Clin Lab Anal. 2016;30(5):672\u20136.","journal-title":"J Clin Lab Anal"},{"issue":"4","key":"3234_CR39","doi-asserted-by":"publisher","first-page":"53219","DOI":"10.31083\/BJHM53219","volume":"87","author":"R Humphrey","year":"2026","unstructured":"Humphrey R, Bowman L. LDL-cholesterol lowering therapies: an update. Br J Hosp Med (Lond). 2026;87(4):53219.","journal-title":"Br J Hosp Med (Lond)"},{"issue":"1","key":"3234_CR40","doi-asserted-by":"publisher","first-page":"427","DOI":"10.1186\/s12933-024-02518-2","volume":"23","author":"Y Yang","year":"2024","unstructured":"Yang Y, Li S, Ren Q, Qiu Y, Pan M, Liu G, Zheng R, An Z, Li S. The interaction between triglyceride-glucose index and visceral adiposity in cardiovascular disease risk: findings from a nationwide Chinese cohort. Cardiovasc Diabetol. 2024;23(1):427.","journal-title":"Cardiovasc Diabetol"},{"issue":"12","key":"3234_CR41","doi-asserted-by":"publisher","first-page":"e6381","DOI":"10.1097\/MD.0000000000006381","volume":"96","author":"S Zhang","year":"2017","unstructured":"Zhang S, Du T, Li M, Lu H, Lin X, Yu X. Combined effect of obesity and uric acid on nonalcoholic fatty liver disease and hypertriglyceridemia. Med (Baltim). 2017;96(12):e6381.","journal-title":"Med (Baltim)"},{"key":"3234_CR42","doi-asserted-by":"crossref","unstructured":"Deusdar\u00e1 R, de Moura Souza A, Szklo M. Positive additive and multiplicative interactions among clustered components of metabolic syndrome with type 2 diabetes mellitus among brazilian adolescent students. Nutrients2022;14(21).","DOI":"10.3390\/nu14214640"},{"key":"3234_CR43","doi-asserted-by":"publisher","first-page":"1809007","DOI":"10.3389\/fendo.2026.1809007","volume":"17","author":"Y Sun","year":"2026","unstructured":"Sun Y, Huang J, Yu X, Meng J, Qiu G. Association of the triglyceride glucose index and its related indices with coronary artery disease risk: mediation by glycated haemoglobin. Front Endocrinol (Lausanne). 2026;17:1809007.","journal-title":"Front Endocrinol (Lausanne)"},{"key":"3234_CR44","doi-asserted-by":"publisher","first-page":"108211","DOI":"10.1016\/j.ypmed.2024.108211","volume":"191","author":"J Wang","year":"2025","unstructured":"Wang J, Zheng Y, Jiang Y, Suo C, Zhang T, Chen X, Xu K. Association between physical activity-related metabolic signature and cardiometabolic diseases and multimorbidity: a cohort study from UK biobank. Prev Med. 2025;191:108211.","journal-title":"Prev Med"},{"key":"3234_CR45","doi-asserted-by":"crossref","unstructured":"Cersosimo E, DeFronzo RA. Insulin resistance and endothelial dysfunction: the road map to cardiovascular diseases. Diabetes Metab Res Rev2006 Nov-Dec;22(6):423\u201336.","DOI":"10.1002\/dmrr.634"},{"issue":"7","key":"3234_CR46","doi-asserted-by":"publisher","first-page":"1793","DOI":"10.1172\/JCI29069","volume":"116","author":"SE Shoelson","year":"2006","unstructured":"Shoelson SE, Lee J, Goldfine AB. Inflammation and insulin resistance. J Clin Invest. 2006;116(7):1793\u2013801.","journal-title":"J Clin Invest"},{"key":"3234_CR47","doi-asserted-by":"publisher","first-page":"154892","DOI":"10.1016\/j.metabol.2021.154892","volume":"125","author":"L Mastrototaro","year":"2021","unstructured":"Mastrototaro L, Roden M. Insulin resistance and insulin sensitizing agents. Metabolism. 2021;125:154892.","journal-title":"Metabolism"},{"key":"3234_CR48","doi-asserted-by":"crossref","unstructured":"Yang M, Su C, Chang X, Wang G, Liu J. Data-driven cluster analysis identifies distinct types of cardiovascular-kidney-metabolic syndrome. Eur J Prev Cardiol2025 Nov 6.","DOI":"10.1093\/eurjpc\/zwaf708"},{"issue":"1","key":"3234_CR49","doi-asserted-by":"publisher","first-page":"101645","DOI":"10.1016\/j.jhepr.2025.101645","volume":"8","author":"XD Zhou","year":"2026","unstructured":"Zhou XD, Song SJ, Guo CY, Chen QF, Lai-Hung Wong G, Ye TR, Bee Goh GB, Bee YM, Lian LY, Cheuk-Fung Yip T, Che-To Lai J, Lei SY, Liu WY, Fan RC, Hong CL, Targher G, Byrne CD, Marot G, Raverdy V, Pattou F, Zheng Lim DY, Wai-Sun Wong V, Zheng MH. Validation of a data-driven clustering model for MASLD: evidence from three large-scale Asian cohorts. JHEP Rep. 2026;8(1):101645.","journal-title":"JHEP Rep"},{"key":"3234_CR50","doi-asserted-by":"crossref","unstructured":"Lim AMW, Lim EU, Chen PL, Fann CSJ. Unsupervised clustering identified clinically relevant metabolic syndrome endotypes in UK and Taiwan Biobanks. iScience2024;27(7):109815.","DOI":"10.1016\/j.isci.2024.109815"}],"container-title":["Cardiovascular Diabetology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12933-026-03234-9","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12933-026-03234-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12933-026-03234-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,11]],"date-time":"2026-08-11T11:04:59Z","timestamp":1786446299000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s12933-026-03234-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6,3]]},"references-count":50,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["3234"],"URL":"https:\/\/doi.org\/10.1186\/s12933-026-03234-9","relation":{},"ISSN":["1475-2840"],"issn-type":[{"value":"1475-2840","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,6,3]]},"assertion":[{"value":"4 April 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 May 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 June 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"As this study was derived from a public database, no additional ethics approval was required.","order":1,"name":"Ethics","label":"Ethics approval and consent to participate","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","label":"Consent for publication","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"224"}}